Volume : 09, Issue : 10, October – 2022

Title:

68.STUDY TO EXPLORE PERSISTENT SYMPTOMS IN PATIENTS AFTER COVID-19 INFECTION IN THE GENERAL POPULATION OF PAKISTAN
‬

Authors :

Dr. Afaq Ahmad, Dr. Muhammad Sheharyar Ahsan, Muhammad Uzair, Asad Riaz, Dr. Humaira Bashir, Dr. Muhammad Faizan

Abstract :

Objectives: To improve the continuity of healthcare and explore the persistent symptoms following Covid 19 recovery
Methods: It was a cross-sectional study, and the patients were recruited by a simple, convenient sampling method. All patients who were at least 18 years of age and met the World Health Organization criteria for cessation of quarantine (no fever for three continuous days, improvement in symptoms, and two negative test results for COVID-19 virus was negative 24 hours apart) were recruited. All the patients included were treated at home. The study was carried out between January 2021 and June 2021 in Islamabad, Pakistan.
The data was collected from the patients through an online standardized questionnaire.
Results: 412 patients were potentially eligible. Twenty-one individuals (5%) refused to participate, and 34 had positive test results. Thus, 357 patients were enrolled. Patients were assessed a mean of 90.6 (SD, 23.5) days after onset of the first COVID-19 symptom, 127 (35.6%) were completely free of any COVID-19–related symptom, while 39.2% had 1 or 2 symptoms and 25.2% had 3 or more symptoms. The mean age was 44.5 (SD, 12.5) years (range, 19-54 years), and 110 (31%) were women. Fatigue, shortness of breath and myalgia were the most common persistent symptoms.
Conclusion: Patients of COVID-19 illness suffer from persistent symptoms even after complete recovery from an acute phase

Cite This Article:

References:

1. Priya, V., and Parvin Abraham. “Computational Designing of a Peptide That Potentially Blocks the Entry of SARS-CoV, SARS-CoV-2 and MERS-CoV.” PLoS One, vol. 16, no. 5, Public Library of Science, May 2021, p. e0251913.
2. Alimohamadi Y, Sepandi M, Taghdir M, Hosamirudsari H. Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg. 2020 Oct 6;61(3):E304-E312. DOI: 10.15167/2421-4248/jpmh2020.61.3.1530. PMID: 33150219; PMCID: PMC7595075.
3. https://www.who.int/news-room/commentaries/detail/criteria-for-releasing-COVID-19-patients-from-isolation
4. Carfì A, Bernabei R, Landi F, for the Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. Published online July 09, 2020.